LITTLE GREEN PHARMA LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1 AUD | -4.76% |
|
0.00% | -28.57% |
Valuation
| Fiscal Period: Marzo | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 131.1 | 116.5 | 42.01 | 30.18 | - |
| Enterprise Value (EV) 1 | 131.1 | 116.5 | 41.91 | 31.18 | 30.88 |
| P/E ratio | 4.72 x | -6.34 x | -5.15 x | -10 x | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | - | 1.64 x | 1.01 x | 0.85 x |
| EV / Revenue | - | - | 1.64 x | 1.05 x | 0.87 x |
| EV / EBITDA | - | - | -12.7 x | 156 x | 9.65 x |
| EV / FCF | - | - | -64.5 x | -12.5 x | 61.8 x |
| FCF Yield | - | - | -1.55% | -8.02% | 1.62% |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 187,275 | 240,211 | 300,093 | 301,761 | - |
| Reference price 2 | 0.7000 | 0.4850 | 0.1400 | 0.1000 | 0.1000 |
| Announcement Date | 8/30/21 | 6/30/22 | 5/30/24 | - | - |
1AUD in Million2AUD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | - | 25.63 | 29.8 | 35.5 |
| EBITDA 1 | - | - | -3.3 | 0.2 | 3.2 |
| EBIT 1 | - | - | -8.652 | -2.7 | 0.4 |
| Operating Margin | - | - | -33.76% | -9.06% | 1.13% |
| Earnings before Tax (EBT) 1 | - | - | -8.153 | -3 | 0.1 |
| Net income 1 | 24.6 | -18.29 | -8.153 | -3 | 0.1 |
| Net margin | - | - | -31.81% | -10.07% | 0.28% |
| EPS 2 | 0.1484 | -0.0765 | -0.0272 | -0.0100 | - |
| Free Cash Flow 1 | - | - | -0.6496 | -2.5 | 0.5 |
| FCF margin | - | - | -2.53% | -8.39% | 1.41% |
| FCF Conversion (EBITDA) | - | - | - | - | 15.62% |
| FCF Conversion (Net income) | - | - | - | - | 500% |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 8/30/21 | 6/30/22 | 5/30/24 | - | - |
1AUD in Million2AUD
Estimates
Balance Sheet Analysis
| Fiscal Period: Marzo | 2021 | 2022 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 1 | 0.7 |
| Net Cash position 1 | - | - | 0.1 | - | - |
| Leverage (Debt/EBITDA) | - | - | - | 5 x | 0.2187 x |
| Free Cash Flow 1 | - | - | -0.65 | -2.5 | 0.5 |
| ROE (net income / shareholders' equity) | - | - | -9.57% | -2.1% | 0.1% |
| ROA (Net income/ Total Assets) | - | - | -8.25% | -2% | 0.1% |
| Assets 1 | - | - | 98.79 | 150 | 100 |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share 2 | - | - | 0 | -0.0100 | 0.0100 |
| Capex 1 | - | - | 0.72 | 1.1 | 1.1 |
| Capex / Sales | - | - | 2.79% | 3.69% | 3.1% |
| Announcement Date | 8/30/21 | 6/30/22 | 5/30/24 | - | - |
1AUD in Million2AUD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.1
AUD
Average target price
0.17
AUD
Spread / Average Target
+70.00%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -28.57% | 21.48M | |
| +9.94% | 4.99B | |
| -32.21% | 3.61B | |
| -1.43% | 3.1B | |
| -25.09% | 2.64B | |
| -11.46% | 2.32B | |
| +36.65% | 1.85B | |
| +37.15% | 1.43B | |
| -16.01% | 1.39B | |
| +40.95% | 1.37B |
- Stock Market
- Equities
- LGP Stock
- Financials Little Green Pharma Ltd
